Offers tax credits to companies making medical supplies and drugs in the U.S.
This bill would give tax breaks to companies that make important medical supplies and drugs in the United States. It also offers credits for new, advanced equipment and for meeting environmental rules. The goal is to reduce reliance on foreign supply chains for healthcare.
Today, there are no specific tax credits for making critical medical supplies in the U.S. or for related equipment. This bill would create three new tax credits: a 10.5 percent credit for domestic manufacturing income, and investment credits of up to 30 percent for advanced equipment and environmental compliance equipment. These changes would start for tax years beginning after December 31, 2026, for manufacturing, and after the bill becomes law for equipment.
S 4994 · 119th Congress · July 15, 2026 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers